Nerve Repair & Regeneration Market Forecast: Increasing R&D Investments & Research Expenditure to Drive Growth

DUBLIN, June 27, 2022 /PRNewswire/ -- The "Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%. The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products.

The biomaterial as segment is anticipated to grow at the fastest growth rate during the forecast period.

Based on product type, the nerve repair and regenerations market is segmented into neurostimulation and neuromodulation devices and biomaterials. The biomaterials segment is expected to register the highest CAGR which is driven by the research investments, and R&D expenditure by the government and market players.

The internal neurostimulation and neuromodulation segment is accounted for the largest share during the analysis period.

Based on the neurostimulation and neuromodulation application, the nerve repair & regeneration market is segmented the neurostimulation and neuromodulation devices market is segmented into internal neurostimulation and neuromodulation applications and external neurostimulation and neuromodulation applications. The internal neurostimulation neuromodulation segment is held the largest share during the forecast period owing to the rising cases of nerve related injuries and the high incidence of neurological disorders.

Asia Pacific is estimated to register the highest CAGR during the study period. North America is expected to dominate the market share

In this report, the nerve repair & regeneration market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Middle East & Africa and Latin America). In 2021, North America held the largest share of the market owing to the presence of the leading players and advanced healthcare infrastructure.

The market in Asia Pacific is projected to grow at the highest growth rate during the forecast period owing to the massive population base, increasing economical growth, improving healthcare infrastructure and healthcare expenditure, high reverence of the neurologic diseases and the rising demandKey Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Nerve Repair & Regeneration Market Overview
4.2 Nerve Repair & Regeneration Market, by Product & Country (2021)
4.3 Nerve Repair & Regeneration Market, by Region (2022 Vs. 2027)
4.4 Nerve Repair & Regeneration Market: Geographic Growth Opportunities

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 21 Nerve Repair & Regeneration Market: Drivers, Restraints, Opportunities, and Challenges
5.2.1 Drivers
5.2.1.1 High Incidence of Nerve Injuries
5.2.1.2 Rising Focus on Neuromodulation & Neurostimulation Technologies
5.2.1.3 Rising Geriatric Population and the Subsequent Increase in the Prevalence of Neurological Disorders
5.2.1.4 Rising Government Support for Research on Neurological Disorders
Figure 22 Funding for Research by the Nih (Us)
5.2.2 Opportunities
5.2.2.1 Emerging Markets
5.2.2.2 Advances in Stem Cell Therapy in Nerve Repair & Regeneration
5.2.2.3 Growing Research Projects in Neurology
5.2.3 Challenges
5.2.3.1 Donor-Site Morbidity
5.2.3.2 Difficulties in Treating Large Nerve Gaps
5.2.3.3 Stringent Regulatory Frameworks and Time-Consuming Approval Processes
5.2.3.4 Greater Preference for Drug Therapies Over Nerve Repair & Regeneration Products
5.2.3.5 Shortage of Trained Professionals
5.2.3.6 Product Recalls
Table 6 Major Product Recalls
5.3 Impact of COVID-19 on the Nerve Repair & Regeneration Market
5.4 Pricing Analysis

6 Nerve Repair & Regeneration Market, by Product
6.1 Introduction
6.2 Neurostimulation and Neuromodulation Devices
6.3 Biomaterials

7 Nerve Repair & Regeneration Market, by Application
7.1 Introduction
7.2 Neurostimulation & Neuromodulation
7.3 Nerve Repair & Regeneration Biomaterials

8 Nerve Repair & Regeneration Market, by Region

9 Competitive Landscape

 Companies Mentioned

• Abbott Laboratories
• Alafair Biosciences, Inc.
• Aleva Neurotherapeutics Sa
• Axogen Corporation.
• Baxter
• Biowavego USA
• Boston Scientific Corporation
• Checkpoint Surgical Inc.
• Collagen Matrix Inc
• Electrocore, Inc.
• Gimer Medical
• Integra Lifesciences
• Kerimedical
• Livanova plc
• Medtronic, plc.
• Neuronetics Inc.
• Neuropace Inc.
• Neurosigma, Inc.
• Nevro Corp.
• Polyganics
• Renishaw plc.
• Soterix Medical Inc.
• Synapse Biomedical Inc
• Tvns Technologies Gmbh

For more information about this report visit https://www.researchandmarkets.com/r/keky7r

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED